146,498 RSUs awarded to PACS Group (PACS) president & COO

Rhea-AI Filing Summary

Jergensen Joshua reported acquisition or exercise transactions in this Form 4 filing.

PACS Group, Inc. reported that President & COO Joshua Jergensen received an award of 146,498 restricted stock units (RSUs) of Common Stock. After this grant, he holds 2,813,845 shares directly. The RSUs vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, subject to his continued service.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Jergensen Joshua

Role President & COO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	146,498	$0.00	--

Holdings After Transaction: Common Stock — 2,813,845 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jergensen Joshua

(Last) (First) (Middle)

C/O PACS GROUP, INC.

90 S. 400 W. SUITE 700

(Street)

SALT LAKE CITY UTAH 84101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/24/2026		A		146,498(1)	A	$0	2,813,845	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, subject to the Reporting Person's continued service through the applicable vesting date.

Remarks:

	/s/ John Mitchell, Attorney-in-Fact	03/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did PACS Group (PACS) disclose about Joshua Jergensen in this Form 4?

PACS Group reported that President & COO Joshua Jergensen received 146,498 restricted stock units of Common Stock. These RSUs are part of his equity compensation and increase his direct holdings to 2,813,845 shares after the award.

How many PACS Group (PACS) RSUs were granted to the President & COO?

The filing shows an award of 146,498 restricted stock units to President & COO Joshua Jergensen. Each RSU represents the right to receive one share of PACS Group Common Stock upon vesting, according to the disclosed terms.

What is the vesting schedule for Joshua Jergensen’s PACS Group (PACS) RSUs?

The RSUs vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026. Vesting is conditioned on Joshua Jergensen’s continued service with PACS Group through each applicable vesting date.

How many PACS Group (PACS) shares does Joshua Jergensen own after this grant?

After the RSU award, Joshua Jergensen’s direct holdings total 2,813,845 shares of PACS Group Common Stock. This figure includes the impact of the newly granted 146,498 restricted stock units reported in the Form 4.

Does the PACS Group (PACS) Form 4 indicate a market purchase or sale?

No market purchase or sale is reported. The Form 4 reflects a grant or award acquisition of 146,498 restricted stock units to Joshua Jergensen as compensation, with no per-share purchase price and no disposition of existing shares.